Shares of Health Care sector company Catalent moved -0.3% today, and are now trading at a price of $47.07. The large-cap stock's daily volume was 91,506 compared to its average volume of 2,624,947. The S&P 500 index returned a -0.0% performance.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The company is based in Somerset and has 17,800 full time employees. Its market capitalization is $8,485,403,136.
14 analysts are following Catalent and have set target prices ranging from $44.0 to $58.0 per share. On average, they have given the company a rating of hold. At today's prices, CTLT is trading -8.23% away from its average analyst target price of $51.29 per share.
Over the last year, CTLT shares have gone down by -46.0%, which represents a difference of -62.0% when compared to the S&P 500. The stock's 52 week high is $89.69 per share and its 52 week low is $31.45.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-08-29 | 439,000 | -660,000 | 1,099,000 | -1.79 |
| 2021-08-30 | 433,000 | -686,000 | 1,119,000 | 23.51 |
| 2020-08-31 | 440,000 | -466,000 | 906,000 | 94.84 |
| 2019-08-27 | 248,000 | -217,000 | 465,000 | -15.33 |
| 2018-08-28 | 374,500 | -174,700 | 549,200 | 25.22 |
| 2017-08-28 | 299,500 | -139,100 | 438,600 |
